For decades, pharmacy automation has been defined by what it can do mechanically — count, sort, dispense. Robots fill bins. Barcode systems flag errors. Cabinets track controlled substances. These are meaningful advances, but they represent only the beginning of what’s…
Pharmacy
The U.S. Supreme Court has declined to hear petitions from six major drugmakers challenging the Medicare Drug Price Negotiation Program, leaving in place lower court rulings that upheld the program and effectively closing off the industry’s best remaining path to…
The Trump administration has expanded TrumpRx to include more than 600 generic medications — a significant scale-up from the platform’s original focus on branded drugs under most-favored-nation pricing agreements. The new generic listings will sit separately from the branded drug…
Pharmacy and clinical teams are operating in one of the most demanding environments in recent memory. Staffing shortages, accelerated by the pandemic and compounded by an aging patient population, are forcing health systems to do more with less — and…
The FDA has approved AstraZeneca’s Baxfendy to treat uncontrolled hypertension, marking the first approval for an aldosterone synthase inhibitor in the indication. Baxfendy, also known as baxdrostat, is indicated for patients with uncontrolled or treatment-resistant hypertension and is intended for…
Advertisement
Federal ethics disclosures published recently show President Donald Trump’s accounts purchased Eli Lilly stock on at least seven occasions in the first quarter of 2026 — a period in which his administration took a series of actions that directly benefited…
For Andrea Jarzyniecki, PharmD, director of pharmacy at Thomasville, Ga.-based Archbold Medical Center, a platform-based approach to medication management has led to measurable results: $1.9 million in avoided waste, 512 stockouts avoided and a 20% reduction in technician inventory labor.…
Becker’s asked pharmacy executives from hospitals and health systems, along with academic medical centers and universities across the U.S. to share the future of AI in the pharmacy workforce field. The 16 executives featured in this article are all speaking…
The FDA has declined to approve Replimune’s biologics license application for vusolimogene oderparepvec in combination with nivolumab for adults with unresectable advanced cutaneous melanoma. The agency first rejected the application in a July 21, 2025, complete response letter and reaffirmed…
CVS Health secured court approval to sell its long-term care pharmacy business, Omnicare, according to a May 14 news release and bankruptcy court filings. GenieRx, a partnership between a private investment firm and a healthcare investment and management firm, is…